Clinician scientists and scientists from the National Cancer Centre Singapore and A STAR's Genome Institute of Singapore, in collaboration with Singapore General Hospital, the National University Health System, Duke-NUS Medical School, Nanyang Technological University, and collaborators from China, Malaysia, Thailand and the Philippines, have described a dynamic genomic landscape of tumour heterogeneity in hepatocellular carcinoma (HCC).
/PRNewswire/ Cargene Biopharma Inc. ("Cargene") announced today the close of an over-subscribed US$19.2 million pre-Series A funding round. The financing.
/PRNewswire/ Cargene Biopharma Inc. ("Cargene") announced today the close of an over-subscribed US$19.2 million pre-Series A funding round. The financing.